Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Epratuzumab (Anti-Siglec-2 / CD22) For research use only.
Not for use in humans.

Epratuzumab (Anti-Siglec-2 / CD22)

Synonyms: Antibody hLL 2

Epratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.

Epratuzumab (Anti-Siglec-2 / CD22)

Purity & Quality Control

Batch: A305601 Purity: 99% Protein concentration: 15.36mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Epratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.

Product Details

CAS No. 205923-57-5
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Epratuzumab (Anti-Siglec-2 / CD22) | Epratuzumab (Anti-Siglec-2 / CD22) supplier | purchase Epratuzumab (Anti-Siglec-2 / CD22) | Epratuzumab (Anti-Siglec-2 / CD22) cost | Epratuzumab (Anti-Siglec-2 / CD22) manufacturer | order Epratuzumab (Anti-Siglec-2 / CD22) | Epratuzumab (Anti-Siglec-2 / CD22) distributor